Literature DB >> 29862143

Alerting the body to tissue injury: The role of alarmins and DAMPs in cutaneous wound healing.

Traci A Wilgus1.   

Abstract

PURPOSE OF REVIEW: Tissue injury stimulates an inflammatory response that is mediated in part by alarmins. Alarmins are a group of endogenous molecules that trigger inflammation in response to damage. This class of molecules is becoming increasingly recognized for their ability to influence wound healing. This article will provide an overview of alarmins and outline the latest findings on these mediators in cutaneous wound healing. RECENT
FINDINGS: In addition to stimulating inflammatory cells, recent evidence suggests that alarmins can act on other cells in the skin to affect wound closure and the extent of scar tissue production. This review will focus on HMGB-1 and IL-33, two alarmins that have received recent attention in the wound healing field.
SUMMARY: Because a properly regulated inflammatory response is critical for optimal healing, further research must be done to fully understand the role of alarmins in the wound repair process.

Entities:  

Keywords:  HMGB-1; IL-33; Inflammation; Repair; Skin; Wound

Year:  2018        PMID: 29862143      PMCID: PMC5978745          DOI: 10.1007/s40139-018-0162-1

Source DB:  PubMed          Journal:  Curr Pathobiol Rep        ISSN: 2167-485X


  42 in total

1.  IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.

Authors:  Alissa A Chackerian; Elizabeth R Oldham; Erin E Murphy; Jochen Schmitz; Stefan Pflanz; Robert A Kastelein
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

2.  Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine.

Authors:  Stefania Mitola; Mirella Belleri; Chiara Urbinati; Daniela Coltrini; Bianca Sparatore; Marco Pedrazzi; Edon Melloni; Marco Presta
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 3.  Scarless wound healing: chasing the holy grail.

Authors:  Graham G Walmsley; Zeshaan N Maan; Victor W Wong; Dominik Duscher; Michael S Hu; Elizabeth R Zielins; Taylor Wearda; Ethan Muhonen; Adrian McArdle; Ruth Tevlin; David A Atashroo; Kshemendra Senarath-Yapa; H Peter Lorenz; Geoffrey C Gurtner; Michael T Longaker
Journal:  Plast Reconstr Surg       Date:  2015-03       Impact factor: 4.730

4.  Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain.

Authors:  Mélanie Pichery; Emilie Mirey; Pascale Mercier; Emma Lefrancais; Arnaud Dujardin; Nathalie Ortega; Jean-Philippe Girard
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

5.  Role of high mobility group box 1 (HMGB1) in wound healing.

Authors:  Qiang Zhang; Sean O'Hearn; Sandra L Kavalukas; Adrian Barbul
Journal:  J Surg Res       Date:  2011-07-29       Impact factor: 2.192

6.  The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.

Authors:  Gaby Palmer; Brian P Lipsky; Molly D Smithgall; David Meininger; Sophia Siu; Dominique Talabot-Ayer; Cem Gabay; Dirk E Smith
Journal:  Cytokine       Date:  2008-05-02       Impact factor: 3.861

7.  Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation.

Authors:  Axel M Küchler; Jürgen Pollheimer; Johanna Balogh; Jon Sponheim; Linda Manley; Dag R Sorensen; Paula M De Angelis; Helge Scott; Guttorm Haraldsen
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

8.  High-mobility group box 1 protein in human and murine skin: involvement in wound healing.

Authors:  Stefania Straino; Anna Di Carlo; Antonella Mangoni; Roberta De Mori; Liliana Guerra; Riccardo Maurelli; Laura Panacchia; Fabio Di Giacomo; Roberta Palumbo; Cristiana Di Campli; Luigi Uccioli; Paolo Biglioli; Marco E Bianchi; Maurizio C Capogrossi; Antonia Germani
Journal:  J Invest Dermatol       Date:  2008-01-31       Impact factor: 8.551

9.  IL-33 promotes Staphylococcus aureus-infected wound healing in mice.

Authors:  Hui Yin; Xiangyong Li; Shilian Hu; Tao Liu; Baohong Yuan; Qian Ni; Fang Lan; Xiaochun Luo; Hongbiao Gu; Fang Zheng
Journal:  Int Immunopharmacol       Date:  2013-07-25       Impact factor: 4.932

10.  High mobility group box 1 contributes to wound healing induced by inhibition of dipeptidylpeptidase 4 in cultured keratinocytes.

Authors:  Tiziana Sinagra; Sara Merlo; Simona F Spampinato; Rocco De Pasquale; Maria Angela Sortino
Journal:  Front Pharmacol       Date:  2015-06-16       Impact factor: 5.810

View more
  10 in total

1.  Skin Wounding-Induced Monocyte Expansion in Mice Is Not Abrogated by IL-1 Receptor 1 Deficiency.

Authors:  Pijus K Barman; Jingbo Pang; Norifumi Urao; Timothy J Koh
Journal:  J Immunol       Date:  2019-03-25       Impact factor: 5.422

Review 2.  Chronic wounds.

Authors:  Vincent Falanga; Roslyn Rivkah Isseroff; Athena M Soulika; Marco Romanelli; David Margolis; Suzanne Kapp; Mark Granick; Keith Harding
Journal:  Nat Rev Dis Primers       Date:  2022-07-21       Impact factor: 65.038

Review 3.  Cutaneous Wound Healing: A Review about Innate Immune Response and Current Therapeutic Applications.

Authors:  Yara Adib; Armand Bensussan; Laurence Michel
Journal:  Mediators Inflamm       Date:  2022-04-25       Impact factor: 4.529

Review 4.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

Review 5.  Using PAMPs and DAMPs as adjuvants in cancer vaccines.

Authors:  Huanyou Sun; Wenwen Hu; Yinan Yan; Zichun Zhang; Yuxin Chen; Xuefan Yao; Ling Teng; Xinyuan Wang; Dafei Chai; Junnian Zheng; Gang Wang
Journal:  Hum Vaccin Immunother       Date:  2021-09-14       Impact factor: 4.526

6.  Dry preserved multilayered fibroblast cell sheets are a new manageable tool for regenerative medicine to promote wound healing.

Authors:  Yutaro Matsuno; Masashi Yanagihara; Koji Ueno; Toshiro Saito; Hiroshi Kurazumi; Ryo Suzuki; Shunsaku Katsura; Atsunori Oga; Kimikazu Hamano
Journal:  Sci Rep       Date:  2022-07-22       Impact factor: 4.996

Review 7.  Cell death in skin function, inflammation, and disease.

Authors:  Holly Anderton; Suhaib Alqudah
Journal:  Biochem J       Date:  2022-08-12       Impact factor: 3.766

8.  Toll-like receptor involvement in adolescent scoliotic facet joint degeneration.

Authors:  Daniel G Bisson; Kai Sheng; Semsi Kocabas; Emerson Krock; Alisson Teles; Neil Saran; Jean A Ouellet; Lisbet Haglund
Journal:  J Cell Mol Med       Date:  2020-08-27       Impact factor: 5.310

Review 9.  Immunology of Acute and Chronic Wound Healing.

Authors:  Kamila Raziyeva; Yevgeniy Kim; Zharylkasyn Zharkinbekov; Kuat Kassymbek; Shiro Jimi; Arman Saparov
Journal:  Biomolecules       Date:  2021-05-08

10.  The Concentration of Selected Inflammatory Cytokines (IL-6, IL-8, CXCL5, IL-33) and Damage-Associated Molecular Patterns (HMGB-1, HSP-70) Released in an Early Response to Distal Forearm Fracture and the Performed Closed Reduction With Kirschner Wire Fixation in Children.

Authors:  Marzena Tylicka; Tomasz Guszczyn; Michał Maksimowicz; Joanna Kamińska; Ewa Matuszczak; Maria Karpińska; Olga Martyna Koper-Lenkiewicz
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-09       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.